Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12)
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this phase III clinical trial was to show safety and efficacy of
Oleogel-S10 in accelerating the wound healing of Split-Thickness Skin Graft (STSG) donor
sites.